Suppression of HIV type 1 replication by a dominant-negative Ets-1 mutant

AIDS Research and Human Retroviruses

Volumn 16, Issue 18, 2000, Pages 1981-1989

  Posada, R ^a   Pettoello Mantovani, M ^a   Sieweke, M ^b   Graf, T ^a   Goldstein, H ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS 1; UNCLASSIFIED DRUG; UPSTREAM STIMULATORY FACTOR 1;

ARTICLE; CONTROLLED STUDY; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

CELL DIVISION; CELL LINE; DNA-BINDING PROTEINS; GENETIC VECTORS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; MUTATION; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; RETROVIRIDAE; T-LYMPHOCYTES; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC; TRANSFECTION; UPSTREAM STIMULATORY FACTORS; VIRUS REPLICATION;

EID: 0034634915     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922200750054710     Document Type: Article

References (34)

1. Control of RNA initiation and elongation at the HIV-1 promoter
2. The regulation of human immunodeficiency virus type-1 gene expression
3. The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation
4. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product
5. Multifaceted activities of the HIV-1 transactivator of transcription, Tat
6. Tat transactivation: A model for the regulation of eukaryotic transcriptional elongation
7. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA
8. HIV-1 Tat interacts with cyclin T1 to direct the P-TEFb CTD kinase complex to TAR RNA
9. Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat
10. Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat
11. HIV-1 Tat transactivator recruits p300 and CREB-binding protein histone acetyl-transferases to the viral promoter
12. A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter
13. An inducible transcription factor activates expression of human immunodeficiency virus in T cells
14. NF-kappa B-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro
15. Chemically selected subclones of the CME cell line demonstrate resistance to HIV-1 infection resulting from a selective loss of NF-kappa B DNA binding proteins
16. Sequence specific binding of the transcription factor c-Ets1 to the human immunodeficiency virus type 1 long terminal repeat
17. Replication of type 1 human immunodeficiency viruses containing linker substitution mutations in the -201 to -130 region of the long terminal repeat
18. Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat
19. Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro
20. Cooperative interaction of ets-1 with USF-1 required for HIV-1 enhancer activity in T cells
21. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS
22. The pCL vector system: Rapid production of helper-free, high-titer, recombinant retroviruses
23. HIV type 1 infection of human fetal bone marrow cells induces apoptotic changes in hematopoietic precursor cells and suppresses their in vitro differentiation and capacity to engraft SCID mice
24. The Ets family of transcription factors
25. The ETS-domain transcription factor family
26. Rapid protection against human immunodeficiency virus type 1 (HIV-1) replication mediated by high efficiency non-retroviral delivery of genes interfering with HIV-1 Tat and Gag
27. Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells
28. Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR
29. Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): Delivery by SV40 provides durable protection against HIV-1 and does not require selection
30. Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1
31. High efficiency retroviral mediated gene transduction into single isolated immature and replatable CD34(3+) hematopoietic stem/progenitor cells from human umbilical cord blood
32. Hematopoietic stem cell-based gene therapy for acquired immunodeficiency syndrome: Efficient transduction and expression of RevM10 in myeloid cells in vivo and in vitro
33. Inhibition of RNA polymerase II transcription in human cells by synthetic DNA-binding ligands
34. Inhibition of Ets-1 DNA binding and ternary complex formation between Ets-1, NF-kappaB, and DNA by a designed DNA-binding ligand